A long-term trial of schizophrenia drugs has found that newer
medications are not any more effective than a first-generation
drug, but questions have been raised about the parameters of the
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.